Drugs / Primaquine Diphosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04049916 | Sep 2019 → Jan 2020 | Plasmodium falciparum malaria | London School of Hygiene and Tropical Medicine | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Primaquine Diphosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04049916 ↗ |
| Route | Oral | “primaquine was administered as a single dose in oral solution according to bodyweight (0·25 mg/kg; in 1 kg bands)” PMID 35028628 ↗ Jan 2022 |